PATH is working in collaboration with LifeAssay Diagnostics, Ltd. (SouthAfrica) to develop and support validation of a simple, low-cost protein-to-creatinine ratiometric urine dipstick test and is seeking to demonstrate the feasibility for implementation and use of the test within routine ANC.
PATH is working in collaboration with LifeAssay Diagnostics, Ltd. (SouthAfrica) to develop and support validation of a simple, low-cost protein-to-creatinine ratiometric urine dipstick test and is seeking to demonstrate the feasibility for implementation and use of the test within routine ANC.
SEE LESS